Cardiology
Iloprost PSK
Registration certificate:
INN:
Iloprost
Release form:
Solution for inhalation
Therapeutic Area:
Cardiology
Pharmacotherapeutic Group:
Antithrombotic agents; platelet aggregation inhibitors excluding heparin
Conditions for dispensing:
On prescription
Packaging:

Indications for Use: 

The drug Iloprost PSK is used in adults over the age of 18 for the treatment of patients with moderate and severe pulmonary hypertension

  • Primary (idiopathic) pulmonary arterial hypertension or familial (present in family medical histories) pulmonary arterial hypertension;
  • Pulmonary arterial hypertension associated with connective tissue disease, or induced by drugs or toxins;
  • Pulmonary hypertension due to chronic formation of dense blood clots (thrombi) in the vessels (chronic thromboembolic disease) and/or acute circulatory disturbances in the lungs caused by obstruction of major arteries or their smaller branches by thrombi (pulmonary embolism), when surgical treatment is not indicated or feasible.

Prescription Status: Rx only.

CONTRAINDICATIONS APPLY. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the leaflet for Iloprost PSK, please visit the open access website at https://grls.rosminzdrav.ru/Default.aspx

Quality control
at all stages of production